BIOCOM Supported Events

The First Event in The Clearity Foundation’s Personalized Medicine Series:

Personalized Medicine Is Failing Patients. How can we make it work?

Tuesday, February 28, 2012

Pfizer Conference Center

5:00pm – 7:30pm

The Clearity Foundation's Personalized Medicine Symposium Series will create a venue for productive discussion of the challenges and opportunities in bringing the promise of personalized medicine to reality. Our first panel will explore some of the commercial issues in bringing personalized medicine to patients. Please join us at the Pfizer conference center for an outstanding panel presentation, networking, discussion, drinks and appetizers.

Personalized Medicine Is Failing. How can we make it work?

Moderated by: David Nelson, PhD, Epic Sciences

The unlikely success of Crizotinib: ALK targeting for lung cancer: Jamie Christensen, MD Director of Translational Pharmacology, Pfizer

Personalized treatment from the patient’s perspective: Allen Fremont, MD, PhD lung cancer survivor and Co-Director at California Comparative Effectiveness and Outcomes Improvement Center

Intellectual property challenges for personalized medicine: Lisa Haile, Partner, DLA Piper

RSVP
Tuesday February 21, 2012
Please email: patpio@clearityfoundation.org

The Clearity Foundation is the only foundation in America dedicated to improving therapeutic options for women with ovarian cancer now. We believe we are the first organization making personalized medicine a reality for women with this disease. By improving the information used in making treatment decisions, our goal is for women with ovarian cancer to live longer, healthier lives. More at www.clearityfoundation.org.

MDMA has expanded this popular seminar to TWO days, and will focus on unique insights and strategies to govern the 510(k) and PMA regulatory pathways, as well as what changes may come as a result of FDA reform efforts. Presentations will be made by leading FDA attorneys, industry representatives, and FDA officials.

This Seminar Will Cover:

• Formatting and the Necessary Content for a 510(k)

• PMA Review Strategies and Communications

• Clinical Trial Considerations and Compliance Oversight

• How to Avoid Common Mistakes and Roadblocks

The program will provide valuable insight from a variety of perspectives and give companies considering submitting a 510(k) or PMA in the future the tools they need to prepare successful submissions.

This seminar is pre-approved by RAPS as eligible for up to 6 credits towards a participant's RAC recertification upon full completion.

2012 NCI SBIR Investor Forum

April 18, 2012

Aglient Technologies, Aristotle Room

Santa Clara, CA 95051

If you're looking to tap into the next big thing in the cancer space, we encourage you to attend the NCI SBIR Investor Forum on April 18, 2012. The Investor Forum is an exclusive event designed to connect the strongest and most promising NCI SBIR companies with life science investors and strategic partners. In 2010, relationships established at the NCI SBIR Investor Forum resulted in more than $225 million in deals to advance companies on the cutting-edge of cancer technology development.

Highlights of this full-day conference include:

• Get a sneak preview of the top 10-15 early-stage oncology companies currently funded by the NCI and learn about some of the latest cancer technology and therapeutic developments.

• Connect with 200 investors, venture capitalists, deal-makers, scientists, and small business leaders from the biotech and pharmaceutical industries.

• Engage in private breakout sessions and a networking reception with featured companies.

• Meet one-on-one with NCI leadership to gain new insights on funding and partnership opportunities and hear updates on new programs to accelerate promising cancer-related technologies to commercialization.

Registration is free, but limited. Investors and venture capitalists are invited to click here to register to reserve a space.

ChinaBio® Partnering Forum 2012 Capturing Innovation in China™

May 23–24, 2012

Dushu Lake Hotel,

299 Qiyue Street, Suzhou Industrial Park, Jiangsu 215123

Suzhou, China

ChinaBio® Partnering Forum is the premier life science partnering event in China. To be held on May 23–24, 2012 in Suzhou, the fourth edition of the event will gather biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. In addition, the successful Innovation Showcase track will feature top researchers from leading institutes and universities throughout China.

ChinaBio® Partnering Forum 2011 attracted 644 attendees from 370 companies who participated in 807 one-to-one meetings facilitated by partneringONE®, making it the largest partnering conference in China.

May 21-23, 2012
The Sheraton San Diego Hotel and Marina

Come join us for the 2012 AAPS National Biotechnology Conference! The scientific programming will feature 19 symposia, 17 roundtables and mini-symposia, eight sunrise sessions, three short courses, two workshops and a brand new Advanced Immunogenicity training course. All sessions are planned around the following themes:

•Antibody Drug Conjugates
•Bioanalysis
•Biosimilar/Biobetters
•Biotherapeutics Drug Development
•Biotherapeutics Drug Discovery
•Biotherapeutics Pharmaceutical Sciences
•Drug Delivery (Non-invasive and Minimally Non-invasive)
•Innovative Drug Delivery
•Translational Research
•Vaccines

Scientists are encouraged to submit contributed papers for the National Biotechnology Conference by clicking here. The submission deadline is January 25, 2012.

We look forward to seeing you in San Diego!

BioPharm America™ 2012—5th Annual International Partnering Conference

September 19–21, 2012

Westin Boston Waterfront

425 Summer Street

Boston, Massachusetts 02210, USA

BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2011, BioPharm America attracted 950+ delegates from 588 companies who participated in 2,550+ scheduled one-to-one meetings.

Drug Development Boot Camp
Harvard University with the Office of Technology Development and Speid & Associates, Inc.
November 14-15, 2012

Why Drug Development Boot Camp?Drug development is a complex process. Each compound or molecule that enters drug development requires a unique drug development program to be devised by the Project Team. Even after many years of working in drug development, many executives with decision making authority lack in-depth understanding of the drug development process.The Drug Development Boot Camp was founded by Dr. Lorna Speid. She is a global regulatory affairs and drug development expert. After watching many of her clients make avoidable and expensive mistakes, she decided to help as many as she could avoid those mistakes. The third Boot Camp will be held with Harvard University OTD at the Harvard Club on November 14-15, 2012.

What is the Drug Development Boot Camp?The Drug Development Boot Camp is a unique, intensive, integrated drug development training which immerses the participants in drug development using a unique approach pioneered by Dr. Lorna Speid. A world quality expert Faculty that have worked together to develop the Boot Camp materials will teach the Boot Camp. Not only will you have fun at the Boot Camp, but you will be totally immersed in the principles of drug development for two days, allowing you to take your drug development skills to another level.

Why Should I travel all the way to Boston for this Boot Camp? You are probably thinking “Why should I take the trouble of flying all the way to the Boston for this Boot Camp when there are many similar courses here in San Diego?” Be assured that there is nothing like the Drug Development Boot Camp at Harvard University with the Office of Technology Development and Speid & Associates.

I can’t afford the cost of the tuition and travel to attend the Boot Camp The mistakes that are made by companies are incredibly expensive. The price of the Boot Camp was set deliberately low to encourage participation by those that need to attend. The cost of not taking this course will far outweigh the cost of this very reasonably priced Boot Camp.

We are very pleased to be able to announce a 100 USD discount off the advertised price if you mention that you are a member of BIOCOM when you sign up to take the Boot Camp. Contact Dr. Lorna Speid at lspeid@sndtm.com or telephone number 858 793 1295.